‘A little bit more certainty’: After shaky years, Mass. life science companies find glimmers of hope
As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...
Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
The researchers found dog foods with the highest carbon impact generated up to 65 times more emissions than those with the ...
Pharma stocks are back in focus as obesity drugs, HIV prevention and biotech deal activity shape the outlook heading into ...
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
A new partnership to promote Swedish clinical trials has been launched, but concerns remain about a lack of patient voices ...
Danish biotech startup Bactolife has secured more than €30 million in a Series B funding round, marking a significant ...
Nizwa: A landmark research project on the development of a 3D-bioprinted wound dressing in the health sector has secured ...
DHL Supply Chain has completed the construction of a one-million-square-foot distribution center of excellence in Annville, ...
Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...
Rakuten Medical has added to its tally of mega-rounds, pocketing another $100 million to push its lead light-based cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results